✨ Free AI Report
Actelion Ltd.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Actelion Ltd.
Company Research

Actelion Ltd.: Business Overview, Financials & Competitive Analysis

Actelion Pharmaceuticals Ltd. is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland, and is part of Johnson & Johnson Innovative Medicine busin...

Analyst-debate audio for Actelion Ltd.

AskCyborg analysts argue the bull and bear cases for Actelion Ltd. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

A disciplined orphan/rare disease specialist with durable market position and multi-modal PAH treatment portfolio, anchored by...

Read the full analyst-debate transcript →
Industry Orphan Drugs
1 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Actelion Ltd. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Actelion Ltd. Overview

Pro stress-test →

Actelion Pharmaceuticals Ltd. is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland, and is part of Johnson & Johnson Innovative Medicine business segment. Actelion focuses on the manufacture of drugs that treat rare and orphan diseases.

Strategic Profile

Pro stress-test →

Actelion, a part of the Johnson & Johnson Family of Companies, is a global leader in the treatment of pulmonary arterial hypertension (PAH), a serious condition affecting the pulmonary arteries and the right side of the heart. The company has several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods.

Competitive Landscape

Pro stress-test →

Regeneron Pharmaceuticals, United Therapeutics, Grifols, AB Science, and ACADIA Pharmaceuticals are some of the competitors of Actelion Pharmaceuticals. Actelion competes primarily in the PAH therapeutic space against specialized and larger pharmaceutical companies offering alternative treatment modalities and patient pathways.

Industry Context

Actelion Ltd. operates in Orphan Drugs.

Key facts

Founded: 1997 · Headquarters: Allschwil, Switzerland · Employees: 2,624

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Actelion Ltd..

  • Actelion was acquired by Johnson & Johnson (June 2017), providing access to global distribution and R&D resources while maintaining focused rare-disease operations
  • Actelion also offers treatments for other serious illnesses, including type 1 Gaucher disease, Niemann-Pick type C disease, and digital ulcers in patients with systemic sclerosis, diversifying beyond PAH
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2024Transferred worldwide rights (excluding US/Canada) for PONVORY® multiple sclerosis treatment to Juvissé Pharmaceuticals
  • December 2023Sold rights to Actelion's multiple sclerosis drug to Vanda Pharmaceuticals
  • +1 moreTrack every material event for Actelion Ltd. as it happens. Explore monitoring →
Get alerted when Actelion Ltd. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Selexipag/Uptravi competitor productsPAH treatment and lung transplantation support→

Compare Actelion Ltd. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Actelion Ltd. operates in Orphan Drugs. See how the rest of the sector scores on the Cyborg framework.

Browse Orphan Drugs research →
NEW · MCP server

Ask your AI assistant about Actelion Ltd.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Actelion Ltd. and its top competitor on Cyborg Score”
“What did Actelion Ltd. do this quarter?”
“Is Actelion Ltd. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Actelion Ltd. do?+
Actelion Pharmaceuticals Ltd. is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland, and is part of Johnson & Johnson Innovative Medicine busin...
What is Actelion Ltd.'s Cyborg Score?+
Actelion Ltd. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Actelion Ltd.'s main competitors?+
Named competitors include Selexipag/Uptravi competitor products. The full competitive landscape is in the AskCyborg report.
How can I get the full Actelion Ltd. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Actelion Ltd. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Actelion Ltd. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.